These observations align with Miao et al. (2020), who reported analogous effects in models of cell migration and vascular remodeling, thereby underscoring the therapeutic potential of targeting the TLR2–CXCR4 axis in cardiovascular diseases. This evidence concerns the gene TLR2 and cardiovascular disorder.